tirzepatide shortages Lilly's weight-loss drug removed from FDA's shortage list Mounjaro will remain off shortage

Non-diabetic patients with genetic variants in GLP1R, GIPR, FTO, or MC4R pathways may benefit from precision dosing strategies that maximize efficacy while minimizing side effects, making personalized testing particularly valuable for optimizing outcomes

However, we still dont have strong evidence showing that GLP-1 medications directly improve live birth rates or long-term fertility outcomes

This makes protein optimization and resistance training even more critical for older researchers, who should aim for the higher end of protein recommendations (1.2 to 1.6 grams per kilogram daily) and prioritize strength training over cardiovascular exercise

Common issues reported with both branded and generic forms include: Nausea Diarrhea or constipation Mild stomach discomfort Most side effects are manageable and often decrease as your body adjusts